Neurotransmitters are chemicals that are secreted by neurons and relay messages to target cells. The goal of in vivo electrochemistry is to provide a real-time view of neurotransmitters in the extracellular space of the brain. This may be done in brain slices or the intact brain of anesthetized animals to probe the basic functions that regulate neurotransmitter levels. In other experiments, the measurements need to be made in the brain of behaving animals so that correlations of neurotransmitter fluctuations and specific behaviors can be made. For the neurotransmitter dopamine this can be accomplished today by chemical sensing of this neurotransmitter with fast scan cyclic voltammetry (FSCV) at carbon-fiber microelectrodes. Dopamine is an important target because it is a central player in the brain 'reward' system, although its precise function is not understood. Proposed roles for dopamine in reward have included the mediation of hedonia (pleasure) 1 , a messenger of incentive salience (wanting) 2 , or an error signal that promotes the learning associated with goal-directed behavior 3,4 . These multiple interpretations of dopaminergic function have arisen because, until recently, a realtime view of dopamine and its actions in an awake, behaving animal was unavailable. At the same time, new electrochemical technologies are being developed to measure other neurotransmitter actions. Electrochemical approaches are well suited for this application because they allow a neurotransmitter to be measured with high time resolution, enabling its precise role in the execution of behavioral tasks to be investigated.In this review we will describe current methods to detect neurotransmitters and monitor their concentration dynamics within neural tissue. The requirements for these methods are quite stringent. They need to be sufficiently selective so that the measured responses are unequivocally due to a specific molecule. They need to be sufficiently sensitive that they can detect these substances in the physiological range. The best established methodologies are for dopamine, so the majority of the applications of the methods described herein will involve this neurotransmitter. As will be seen, the goals in measuring neurotransmitter functions are diverse. On one hand, investigators are unraveling the mechanisms that control neurotransmitter concentrations. These studies range from examining biochemical synthesis to metabolism. On the other hand, investigators are questioning how the neurotransmitter interacts with its receptors and what message it conveys. Yet a third major interest is the role of a neurotransmitter in specific behaviors. To obtain a complete view of neurotransmission and information processing, chemical sensors need to be combined with traditional neurochemical tools. We will illustrate this approach with some specific examples.

Fast-scan cyclic voltammetry has been used in a variety of applications and has been shown to be especially useful to monitor chemical fluctuations of neurotransmitters such as dopamine within the mammalian brain. A major limitation of this procedure, however, is the large amplitude of the background current relative to the currents for the solution species of interest. Furthermore, the background tends to drift, and this drift limits the use of digital background subtraction techniques to intervals less than 90 s before distortion of dopamine signals occurs. To minimize the impact of the background, a procedure termed analog background subtraction is reported here. The background is recorded, and its inverse is played back to the current transducer during data acquisition so that it cancels the background in subsequent scans. Background drift still occurs and is recorded, but its magnitude is small compared to the original background. This approach has two advantages. First it allows the use of higher gains in the current transducer, minimizing quantization noise. Second, because the background amplitude is greatly reduced, principal component regression could be used to separate the contributions from drift, dopamine, and pH when appropriate calibrations were performed. We demonstrate the use of this approach with several applications. First, transient dopamine fluctuations were monitored for 15 min in a flowing injection apparatus. Second, evoked release of dopamine was monitored for a similar period in the brain of an anesthetized rat. Third, dopamine was monitored in the brain of freely moving rats over a 30 min interval. By analyzing the fluctuations in each resolved component, we were able to show that cocaine causes significant fluctuations in dopamine concentration in the brain while those for the background and pH remain unchanged from their predrug value.

Electrochemical detection is becoming increasingly important for the detection of biological species. Most current biological research with electrochemical detection is done with carbon fiber electrodes due to their many beneficial properties. The ability to build electrochemical sensor from noble metals instead of carbon fibers may be beneficial in developing inexpensive multiplexed electrochemical detection schemes. To advance understanding and to test the feasibility of using noble metal electrochemical sensors the detection of dopamine, a biologically important small molecule was studied here. Specifically, dopamine detection on gold microelectrodes was characterized and compared to P-55 carbon fiber microelectrodes of the same geometry, using background subtracted fast scan cyclic voltammetry. While not as sensitive to dopamine as carbon fibers, it was observed that gold microelectrodes have six times the saturation coverage per area and 40 times the linear working range. Selectivity to dopamine, in comparison to several other neurotransmitters and their derivatives, is also quantitatively described.

This article intends to summarize the current views of the IQ Consortium Dissolution Working Group, which comprises various industry companies, on the roles of dissolution testing throughout pharmaceutical product development, registration, commercialization, and beyond. Over the past 3 decades, dissolution testing has evolved from a routine and straightforward test as a component of end-product release into a comprehensive set of tools that the developer can deploy at various stages of the product life cycle. The definitions of commonly used dissolution approaches, how they relate to one another and how they may be applied in modern drug development, and life cycle management is described in this article. Specifically, this article discusses the purpose, advantages, and limitations of quality control, biorelevant, and clinically relevant dissolution methods.

Elliptical and cylindrical geometries of carbon-fiber microelectrodes were modified by covalent attachment of 4-sulfobenzenediazonium tetrafluoroborate following its electroreduction. Elliptical electrodes fabricated from Thornel P-55 carbon fibers show the highest amount of 4-sulfobenzene attached to the electrode. Fast-scan cyclic voltammetry was used to compare the response to dopamine and other neurochemicals at these modified carbon-fiber microelectrodes. The grafted layer causes an increased sensitivity to dopamine and other positively charged analytes that is due to increased adsorption of analyte in the grafted layer. However, this layer remains permeable to negatively charged compounds. Modified electrodes retain the increased sensitivity for dopamine during measurements in mouse brain tissue.